The Journal of Immunology · 2001 · 152 citations · 53 references
Life SciencesBiochemistryMolecular BiologyGene ExpressionInflammationSignal TransductionAngiogenesisCytokine BiologyCytokine SignalingInflammatory SignalingMultiple SclerosisNeuroinflammationMatrix Metalloproteinase Gene ExpressionMatrix Metalloproteinase Gene RegulationMatrix Metalloproteinase ModulationMatrix MetalloproteinasesPromoter Activity AnalysisProteolytic InactivationProteolytic PathwaysType Iv Collagen
Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases that play crucial roles in proteolytic degradation of the extracellular matrix. Aberrant expression of the 92-kDa type IV collagenase (MMP-9) is implicated in the invasion and angiogenesis process of malignant tumors and in inflammatory diseases of the CNS. We investigated the effects of IFN-gamma and IFN-beta, cytokines used for treating some cancers and multiple sclerosis, on MMP-9 expression in human astroglioma and fibrosarcoma cell lines and primary astrocytes. Our results demonstrate that IFN-gamma and IFN-beta significantly inhibit MMP-9 enzymatic activity and protein expression that is induced by PMA and the cytokine TNF-alpha. The inhibitory effects of IFN-gamma and IFN-beta on MMP-9 expression correlate with decreased steady state MMP-9 mRNA levels and suppression of MMP-9 promoter activity. IFN-gamma- and IFN-beta-mediated inhibition of MMP-9 gene expression is dependent on the transcription factor STAT-1alpha, since IFN-gamma and IFN-beta fail to suppress MMP-9 expression in STAT-1alpha-deficient primary astrocytes and human fibrosarcoma cells. Reconstitution of human STAT-1alpha successfully restores the inhibitory effects of IFN-gamma and IFN-beta on MMP-9 gene expression. Thus, these data demonstrate the critical role of STAT-1alpha in IFN-gamma and IFN-beta suppression of MMP-9 gene expression.
53
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Gabriele Bergers, Rolf A. Brekken, Gerald McMahon et al. · Nature Cell Biology · 2000 · 2.8K citations · Full text
Medicine, Cancer Biology, Oncology +14
CBP/p300 in cell growth, transformation, and development
Richard H. Goodman, Sarah M. Smolik · Genes & Development · 2000 · 1.8K citations · Full text
Metastatic potential correlates with enzymatic degradation of basement membrane collagen
Lance A. Liotta, Karl Tryggvason, Spiridione Garbisa et al. · Nature · 1980 · 1.8K citations
Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease
Joan E. Durbin, Renée Hackenmiller, M. Celeste Simon et al. · Cell · 1996 · 1.6K citations · Full text
Life Sciences, Genetics, Immunology +17